NEW YORK ( TheStreet) -- Biosante Pharmaceuticals (Nasdaq: BPAX) is trading at unusually high volume Wednesday with 5.5 million shares changing hands. It is currently at four times its average daily volume and trading down 15 cents (-6.5%) at $2.16 as of 3:06 p.m. ET. Biosante has a market cap of $151.5 million and is part of the health care sector and drugs industry. Shares are up 40.9% year to date as of the close of trading on Tuesday. BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. TheStreet Ratings rates Biosante as sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally weak debt management. You can view the full Biosante Ratings Report.
More from Markets
Jim Cramer: A Cold War With China Is Worth Avoiding
I wish I could say buy this dip. But the dip is one that's not necessarily going to have an ending today.
China's New Tariffs on U.S. Stem From Domestic Political Calculus, Goldman Says
China's plan to impose new tariffs on U.S. imports might not be the best for the Asian country's economy, but it might be a politically savvy move from the standpoint of the country's leaders, Goldman Sachs says in a report.